Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Cancer Res. 2021 Apr 1;81(7):1681-1694. doi: 10.1158/0008-5472.CAN-20-2222. Epub 2021 Jan 13.
Cancer Res. 2021.
PMID: 33441310
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.
Fernandez ML, Dawson A, Hoenisch J, Kim H, Bamford S, Salamanca C, DiMattia G, Shepherd T, Cremona M, Hennessy B, Anderson S, Volik S, Collins CC, Huntsman DG, Carey MS.
Fernandez ML, et al. Among authors: hoenisch j.
Cancer Cell Int. 2019 Jan 8;19:10. doi: 10.1186/s12935-019-0725-1. eCollection 2019.
Cancer Cell Int. 2019.
PMID: 30636931
Free PMC article.
Item in Clipboard
Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.
Llaurado Fernandez M, Dawson A, Kim H, Lam N, Russell H, Bruce M, Bittner M, Hoenisch J, Scott SA, Talhouk A, Chiu D, Provencher D, Nourmoussavi M, DiMattia G, Lee CH, Gilks CB, Köbel M, Carey MS.
Llaurado Fernandez M, et al. Among authors: hoenisch j.
Gynecol Oncol. 2020 Apr;157(1):12-20. doi: 10.1016/j.ygyno.2019.11.029. Epub 2020 Jan 15.
Gynecol Oncol. 2020.
PMID: 31954537
Item in Clipboard
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition.
Llaurado Fernandez M, Hijmans EM, Gennissen AMC, Wong NKY, Li S, Wisman GBA, Hamilton A, Hoenisch J, Dawson A, Lee CH, Bittner M, Kim H, DiMattia GE, Lok CAR, Lieftink C, Beijersbergen RL, de Jong S, Carey MS, Bernards R, Berns K.
Llaurado Fernandez M, et al. Among authors: hoenisch j.
Mol Cancer Ther. 2022 Dec 2;21(12):1862-1874. doi: 10.1158/1535-7163.MCT-22-0004.
Mol Cancer Ther. 2022.
PMID: 36198031
Free PMC article.
Item in Clipboard
Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.
Fernández ML, DiMattia GE, Dawson A, Bamford S, Anderson S, Hennessy BT, Anglesio MS, Shepherd TG, Salamanca C, Hoenisch J, Tinker A, Huntsman DG, Carey MS.
Fernández ML, et al. Among authors: hoenisch j.
Am J Cancer Res. 2016 Oct 1;6(10):2235-2251. eCollection 2016.
Am J Cancer Res. 2016.
PMID: 27822414
Free PMC article.
Item in Clipboard
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression.
Cheasley D, Fernandez ML, Köbel M, Kim H, Dawson A, Hoenisch J, Bittner M, Chiu DS, Talhouk A, Gilks CB, Jayawardana MW, Pishas KI, Mes-Masson AM, Provencher D, Nigam A, Hacker NF, Gorringe KL, Campbell IG, Carey MS.
Cheasley D, et al. Among authors: hoenisch j.
NPJ Precis Oncol. 2022 Jun 29;6(1):47. doi: 10.1038/s41698-022-00288-2.
NPJ Precis Oncol. 2022.
PMID: 35768582
Free PMC article.
Item in Clipboard
Variable coordination of carbazolyl-bis(tetrazole) ligands in lanthanide chemistry.
Gajecki L , Berg DJ , Hoenisch J , Oliver AG .
Gajecki L , et al. Among authors: hoenisch j.
Dalton Trans. 2018 Nov 21;47(43):15487-15496. doi: 10.1039/c8dt02757a. Epub 2018 Oct 18.
Dalton Trans. 2018.
PMID: 30334555
Item in Clipboard
Cite
Cite